Literature DB >> 11017808

Practice guidelines for the treatment of tuberculosis.

C R Horsburgh1, S Feldman, R Ridzon.   

Abstract

Entities:  

Mesh：

Year:  2000        PMID： 11017808     DOI： 10.1086/314007

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  17 in total

1.  Re-examining treatment of latent tuberculosis infection.

Authors:  B Lynn Johnston; J M Conly
Journal:  Can J Infect Dis       Date:  2001-07

2.  Minimum inhibitory concentrations of herbal essential oils and monolaurin for gram-positive and gram-negative bacteria.

Authors:  Harry G Preuss; Bobby Echard; Mary Enig; Itzhak Brook; Thomas B Elliott
Journal:  Mol Cell Biochem       Date:  2005-04       Impact factor: 3.396

3.  Direct Detection of Pyrazinamide Resistance in Mycobacterium tuberculosis by Use of pncA PCR Sequencing.

Authors:  Kingsley King-Gee Tam; Kenneth Siu-Sing Leung; Gilman Kit-Hang Siu; Kwok-Chiu Chang; Samson Sai-Yin Wong; Pak-Leung Ho; Eunice Ka-Chun Leung; Wing-Cheong Yam
Journal:  J Clin Microbiol       Date:  2019-07-26       Impact factor: 5.948

4.  Comparison of fractional inhibitory concentration index with response surface modeling for characterization of in vitro interaction of antifungals against itraconazole-susceptible and -resistant Aspergillus fumigatus isolates.

Authors:  D T A Te Dorsthorst; P E Verweij; J F G M Meis; N C Punt; J W Mouton
Journal:  Antimicrob Agents Chemother       Date:  2002-03       Impact factor: 5.191

5.  Tuberculous Meningitis in Children.

Authors:  Norman J. Waecker
Journal:  Curr Treat Options Neurol       Date:  2002-05       Impact factor: 3.598

Review 6.  Revised guidelines for the diagnosis and control of tuberculosis: impact on management in the elderly.

Authors:  Paul Van den Brande
Journal:  Drugs Aging       Date:  2005       Impact factor: 3.923

7.  Preparation and in vivo evaluation of a dry powder for inhalation of capreomycin.

Authors:  Jennifer Fiegel; Lucila Garcia-Contreras; Matthew Thomas; Jarod VerBerkmoes; Katharina Elbert; Anthony Hickey; David Edwards
Journal:  Pharm Res       Date:  2007-07-27       Impact factor: 4.200

8.  Concomitant acromioclavicular and miliary tuberculosis.

Authors:  Filon Agathangelidis; Achilleas Boutsiadis; Evangelia Fouka; Dimitrios Karataglis
Journal:  BMJ Case Rep       Date:  2013-06-21

9.  In vitro interactions between amphotericin B, itraconazole, and flucytosine against 21 clinical Aspergillus isolates determined by two drug interaction models.

Authors:  D T A Te Dorsthorst; P E Verweij; J F G M Meis; N C Punt; J W Mouton
Journal:  Antimicrob Agents Chemother       Date:  2004-06       Impact factor: 5.191

10.  Synergistic interactions of methanolic extract of Acacia mearnsii De Wild. with antibiotics against bacteria of clinical relevance.

Authors:  Olufunmiso O Olajuyigbe; Anthony J Afolayan
Journal:  Int J Mol Sci       Date:  2012-07-17       Impact factor: 6.208
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.